KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Intangibles (2016 - 2025)

Opko Health's Intangibles history spans 16 years, with the latest figure at $711.3 million for Q4 2025.

  • For Q4 2025, Intangibles rose 15.36% year-over-year to $711.3 million; the TTM value through Dec 2025 reached $711.3 million, up 15.36%, while the annual FY2025 figure was $711.3 million, 15.36% up from the prior year.
  • Intangibles reached $711.3 million in Q4 2025 per OPK's latest filing, down from $730.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.0 billion in Q4 2022 to a low of $321.7 million in Q4 2021.
  • Average Intangibles over 5 years is $722.8 million, with a median of $754.7 million recorded in 2023.
  • Peak YoY movement for Intangibles: skyrocketed 210.87% in 2022, then plummeted 34.07% in 2024.
  • A 5-year view of Intangibles shows it stood at $321.7 million in 2021, then surged by 210.87% to $1.0 billion in 2022, then fell by 6.47% to $935.3 million in 2023, then tumbled by 34.07% to $616.6 million in 2024, then grew by 15.36% to $711.3 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Intangibles are $711.3 million (Q4 2025), $730.4 million (Q3 2025), and $751.0 million (Q2 2025).